(Q48774158)

15 February 2018

title

Oral aprepitant in the therapy of refractory pruritus in erythrodermic cutaneous T-cell lymphoma (English)

1 reference

15 February 2018

author

Jochen Utikal

6

1 reference

15 February 2018

author name string

N Booken

1

1 reference

15 February 2018

M Heck

2

1 reference

15 February 2018

J P Nicolay

3

1 reference

15 February 2018

C D Klemke

4

1 reference

15 February 2018

S Goerdt

5

1 reference

15 February 2018

language of work or name

English

0 references

publication date

28 January 2011

1 reference

15 February 2018

British Journal of Dermatology

published in

1 reference

15 February 2018

volume

164

1 reference

15 February 2018

issue

3

1 reference

15 February 2018

page(s)

665-667

1 reference

15 February 2018

WHO-EORTC classification for cutaneous lymphomas

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2010.10108.X

Significant impact of cutaneous T-cell lymphoma on patients' quality of life: results of a 2005 National Cutaneous Lymphoma Foundation Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2010.10108.X

Neuropeptides and their receptors in psoriatic skin in relation to pruritus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2010.10108.X

Targeting the neurokinin receptor 1 with aprepitant: a novel antipruritic strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2010.10108.X

Aprepitant for erlotinib-induced pruritus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2010.10108.X

Aprepitant as an antipruritic agent?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2010.10108.X

Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting. Results from a randomized, double-blind, placebo-controlled trial in Latin America

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2010.10108.X

Lack of efficacy of the substance p (neurokinin1 receptor) antagonist aprepitant in the treatment of major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2010.10108.X

Aprepitant against pruritus in patients with solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2010.10108.X

10.1111/J.1365-2133.2010.10108.X

21 January 2018

Identifiers

DOI

1 reference

15 February 2018

1 reference

15 February 2018